» Articles » PMID: 35264785

Identification of a Novel MAGT1 Mutation Supports a Diagnosis of XMEN Disease

Overview
Journal Genes Immun
Date 2022 Mar 10
PMID 35264785
Authors
Affiliations
Soon will be listed here.
Abstract

XMEN (X-linked immunodeficiency with magnesium defect) is caused by loss-of-function mutations in MAGT1 which is encoded on the X chromosome. The disorder is characterised by CD4 lymphopenia, severe chronic viral infections and defective T-lymphocyte activation. XMEN patients are susceptible to Epstein-Barr virus infections and persistently low levels of intracellular Mg. Here we describe a patient that presented with multiple recurrent infections and a subsequent diffuse B-cell lymphoma. Molecular genetic analysis by exome sequencing identified a novel hemizygous MAGT1 nonsense mutation c.1005T>A (NM_032121.5) p.(Cys335*), confirming a diagnosis of XMEN deficiency. Follow-up immunophenotyping was performed by antibody staining and flow cytometry; proliferation was determined by H-thymidine uptake after activation by PHA and anti-CD3. Cytotoxic natural killer cell activity was assessed with K562 target cells using the NKTEST assay. While lymphocyte populations were superficially intact, B cells were largely naive with a reduced memory cell compartment. Translated NKG2D was absent on both NK and T cells in the proband, and normally expressed in the carrier mother. In vitro NK cell activity was intact in both the proband and his mother. This report adds to the growing number of identified XMEN cases, raising awareness of a, still rare, X-linked immunodeficiency.

Citing Articles

Using T-Cell Subsets to Better Characterize Immunoresiliency and Immunodeficiency in Patients with Recurrent Infections.

Hung J, Vonasek B, Rosenberg D, Vo T, Striker R Infect Dis Rep. 2024; 16(6):1230-1239.

PMID: 39728019 PMC: 11675865. DOI: 10.3390/idr16060097.


Revisiting the immunopathology of congenital disorders of glycosylation: an updated review.

Pascoal C, Francisco R, Mexia P, Pereira B, Granjo P, Coelho H Front Immunol. 2024; 15:1350101.

PMID: 38550576 PMC: 10972870. DOI: 10.3389/fimmu.2024.1350101.


Adult-onset neurodegeneration in XMEN disease.

Benavides D, Ebrahim A, Ravell J, Lenardo M, Gahl W, Toro C J Neuroimmunol. 2023; 386():578251.

PMID: 38041964 PMC: 10842803. DOI: 10.1016/j.jneuroim.2023.578251.


CD5 B-Cell Predominant Primary Immunodeficiency: Part of the Spectrum of Deficiency.

Rowane M, Stewart-Bates B, Doll R, Meyerson H, Venglarcik 3rd J, Callahan M Ther Adv Allergy Rhinol. 2023; 14:27534030231199675.

PMID: 37706151 PMC: 10496486. DOI: 10.1177/27534030231199675.


A genome-wide CRISPR functional survey of the human phagocytosis molecular machinery.

Essletzbichler P, Sedlyarov V, Frommelt F, Soulat D, Heinz L, Stefanovic A Life Sci Alliance. 2023; 6(4).

PMID: 36725334 PMC: 9892931. DOI: 10.26508/lsa.202201715.

References
1.
Chester C, Fritsch K, Kohrt H . Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy. Front Immunol. 2015; 6:601. PMC: 4667030. DOI: 10.3389/fimmu.2015.00601. View

2.
Klinken E, Gray P, Pillay B, Worley L, Edwards E, Payne K . Diversity of XMEN Disease: Description of 2 Novel Variants and Analysis of the Lymphocyte Phenotype. J Clin Immunol. 2019; 40(2):299-309. DOI: 10.1007/s10875-019-00732-2. View

3.
Hoyos-Bachiloglu R, Concha S, Sepulveda P, Campos R, Perez-Mateluna G, King A . The Many Faces of XMEN Disease, Report of Two Patients with Novel Mutations. J Clin Immunol. 2020; 40(2):415-417. DOI: 10.1007/s10875-020-00746-1. View

4.
Li F, Chaigne-Delalande B, Su H, Uzel G, Matthews H, Lenardo M . XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus. Blood. 2014; 123(14):2148-52. PMC: 3975255. DOI: 10.1182/blood-2013-11-538686. View

5.
Dhalla F, Murray S, Sadler R, Chaigne-Delalande B, Sadaoka T, Soilleux E . Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease. J Clin Immunol. 2014; 35(2):112-8. PMC: 6328310. DOI: 10.1007/s10875-014-0116-2. View